24 Nov 2014 Date | | - Cons. EPS | - EPS |
19 Aug 2014 Date | | - Cons. EPS | - EPS |
16 Apr 2014 Date | | - Cons. EPS | - EPS |
31 Mar 2014 Date | | - Cons. EPS | - EPS |
20 Nov 2013 Date | | - Cons. EPS | - EPS |
24 Nov 2014 Date | | - Cons. EPS | - EPS |
19 Aug 2014 Date | | - Cons. EPS | - EPS |
16 Apr 2014 Date | | - Cons. EPS | - EPS |
31 Mar 2014 Date | | - Cons. EPS | - EPS |
20 Nov 2013 Date | | - Cons. EPS | - EPS |
- Industry | - Sector | - CEO | OTC GREY Exchange | US4984561021 ISIN |
United States Country | - Employees | - Last Dividend | 28 Aug 2008 Last Split | - IPO Date |
CaliPharms, Inc., formerly known as Kleangas Energy Technologies, Inc., is a company that has pivoted its focus towards the burgeoning field of medicinal cannabis in the United States. With its rebranding in January 2017, the corporation shifted from its previous endeavors into a niche yet rapidly growing sector, targeting the THC and CBD beverage market. Headquartered in Temecula, California, CaliPharms positions itself at the intersection of healthcare and the consumer beverage industry, reflecting the changing societal and legal landscapes surrounding cannabis use for medicinal purposes.
CaliPharms caters to the medicinal cannabis industry with a specific focus on the production and distribution of THC and CBD infused beverages. These products reflect the company’s mission to innovate within the realms of legal cannabis consumption, offering alternatives to traditional smoking or edible methods. Here's a closer look at their product lines: